BACKGROUND: Information about cost of multiple sclerosis (MS) is available from a number of European countries, but no data from the Czech Republic have been published so far. OBJECTIVE: The objective of this study was to establish the cost of MS in the Czech Republic, overall and by level of disease severity. METHODS: Data on demographics, disease history, resource consumption and production losses were collected from 909 patients recruited in 7 MS centres in the Czech Republic. Annual costs were estimated in the societal perspective, using 2007 unit costs. To evaluate the relationship between disability and costs, patients were stratified into those with mild (67%), moderate (27%) and severe (10%) disability using the Expanded Disability Status Scale. RESULTS: Mean total annual costs per patient were €12,272, of which 51% were direct medical costs, 4% direct non-medical costs and 45% indirect costs. The average annual costs in patients with mild, moderate and severe disability amounted to €9905, €14,064 and €22,880, respectively. CONCLUSION: The total costs of MS in the Czech Republic are estimated at €208.6 million per year. Consistent with other studies, the costs increase significantly with the severity of MS.

Department of Neurology and Center of Clinical Neuroscience Charles University Prague 1 Faculty of Medicine and General University Hospital Prague Czech Republic

References provided by Crossref.org

Real-Life Outcome in Multiple Sclerosis in the Czech Republic

The direct costs of multiple sclerosis-study in the Czech Republic

Cognitive clinico-radiological paradox in early stages of multiple sclerosis

Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome